Skip to main content
. 2018 Jan 11;20(4):954–962. doi: 10.1111/dom.13182

Figure 3.

Figure 3

Changes in total insulin and glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) dose from baseline to 6 months. Baseline is defined as last recorded insulin dose before insulin degludec/liraglutide combination (IDegLira) initiation. Data based on effectiveness analysis set. Significance assessed using a two‐tailed paired t test. DDD, defined daily dose; IU, international unit; MDI, multiple daily‐dose insulin injections; ns, non‐significant; OADs, oral antidiabetic drugs